Capturing Outcomes of Clinical Activities Performed by a Rounding Pharmacist Practising in a Team Environment
|Heart Failure, Congestive Pulmonary Disease, Chronic Obstructive Pneumonia Diabetes Mellitus, Type 2 Coronary Arteriosclerosis||Behavioral: Integration of a team based clinical pharmacist Drug: Optimizing therapeutic treatments Behavioral: Optimizing processes of care||Phase 4|
|Study Design:||Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
|Official Title:||Capturing Outcomes of Clinical Activities Performed by a Rounding Pharmacist Practising in a Team Environment (COLLABORATE)|
- Improvement in proportion of quality indicators achieved, for target diseases as a most responsible or primary diagnosis, between groups. [ Time Frame: in hospital ]
- Differences in condition-specific achievement of drug therapy quality indicators; [ Time Frame: in hospital ]
- Differences in 6 month hospital readmission rate; [ Time Frame: 6 months ]
- Differences in number, type, acceptance rate, and expected impact of all pharmacist interventions; [ Time Frame: in hospital ]
- Qualitative evaluation of the impact of the intervention via interviews with the participating pharmacists and physicians. [ Time Frame: in hospital ]
|Study Start Date:||February 2006|
|Study Completion Date:||July 2007|
The overall goal of the COLLABORATE study is to improve processes of care and patient outcomes by optimizing drug therapy via a hospital pharmacy practice model that integrates clinical pharmacists into the patient care team.
The intervention consists of a clinical pharmacist assigned to the patient care team for the purpose of providing proactive clinical pharmacy services. The study pharmacist will be available during normal office hours 5 days per week to provide clarification of the patient's medication history, identify and resolve actual and potential patient specific drug related problems/issues, participate in patient care rounds, provide drug information to the patient care team, provide patient education and discharge medication counselling, and provide physician and/or nursing staff education. The anticipated pharmacist to patient ratio is approximately 1:20.
Control patients will receive usual care. Usual care consists of reactive clinical pharmacy services (i.e. drug related issues identified as orders are received, or by patient profile review) provided by a ward based, not team based, clinical pharmacist.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00351676
|Royal Alexandra Hospital|
|Edmonton, Alberta, Canada, T5H 3V9|
|University of Alberta Hospital|
|Edmonton, Alberta, Canada, T6G 2B7|
|Grey Nuns Community Hospital|
|Edmonton, Alberta, Canada, T6L 5X8|
|Principal Investigator:||Ross T. Tsuyuki, PharmD, MSc||University of Alberta|